EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)Show others and affiliations
2014 (English)In: European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, E-ISSN 1619-7089, Vol. 41, no 11, p. 2175-2185Article in journal (Refereed) Published
Abstract [en]
The preparation of an Investigational Medicinal Product Dossier (IMPD) for a radiopharmaceutical to be used in a clinical trial is a challenging proposition for radiopharmaceutical scientists working in small-scale radiopharmacies. In addition to the vast quantity of information to be assembled, the structure of a standard IMPD is not well suited to the special characteristics of radiopharmaceuticals. This guideline aims to take radiopharmaceutical scientists through the practicalities of preparing an IMPD, in particular giving advice where the standard format is not suitable. Examples of generic IMPDs for three classes of radiopharmaceuticals are given: a small molecule, a kit-based diagnostic test and a therapeutic radiopharmaceutical.
Place, publisher, year, edition, pages
Springer Verlag (Germany) , 2014. Vol. 41, no 11, p. 2175-2185
Keywords [en]
Radiopharmaceutical; Clinical trial; Investigational medicinal product; Guideline
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:liu:diva-112171DOI: 10.1007/s00259-014-2866-8ISI: 000343051700028PubMedID: 25081821OAI: oai:DiVA.org:liu-112171DiVA, id: diva2:764281
2014-11-182014-11-182017-12-05